Tomoko Mineyama

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Ruxolitinib (INC424), a potent and selective oral Janus kinase 1 and 2 inhibitor, was recently approved by the US food and drug administration for the treatment of intermediate or high-risk myelofibrosis. The safety, tolerability, and pharmacokinetics (PK) of ruxolitinib have been extensively evaluated in healthy subjects and patients. The present study is(More)
We have successfully developed multilevel (MLC) contact-less virtual ground array (VGA-NOR) flash memory. Sequential program from the source side edge cell of each segment and 32cells unit program with data buffer enable to cancel the Vt interference. Sense amplifier (SA) assist equalize-sensing (SAES) is implemented for high accuracy sensing operation
  • 1